causal
Genetic Variant Predicts Placebo Response
Studies show that people with a particular variant of a genome region producing a specific enzyme are more likely to have a strong placebo response, a finding supported by large-scale studies (one with 40,000 participants over 10 years) extending beyond irritable bowel syndrome to prevention of heart disease and cancer, while people with a different variant may even be affected negatively by taking a placebo.
causalpending
Speaker
Gary GreenbergEvidence Quote
“People who have one particular variant of a snippet of the genome are more likely to have a strong placebo effect”
Created: 6/13/2026, 12:25:01 AM
Your notes
Loading notes...